颈股脉搏波速度在自身免疫性风湿病中优于SCORE2预测心血管风险
该回顾性队列纳入143例类风湿关节炎、系统性硬化症和脊柱关节炎患者,基线进行颈股脉搏波速度(cfPWV)评估,中位随访7年发生20例心血管事件。cfPWV对心血管事件的判别能力(AUC 0.84)优于SCORE2(AUC 0.56),且为独立预测因子。
要点
- cfPWV对心血管事件判别能力AUC 0.84,优于SCORE2的AUC 0.56。
- 年龄校正后cfPWV仍是心血管事件的显著预测因子(HR 1.19)。
- cfPWV无创,或可为此高危人群心血管风险分层提供增量价值。
核心结论
- cfPWV是自身免疫性风湿病患者未来心血管事件的独立预测因子,长期风险预测优于SCORE2。
研究设计与样本
- 回顾性队列研究,纳入2012至2017年间因至少一项额外心血管危险因素而接受临床指征基线无创cfPWV评估的类风湿关节炎、系统性硬化症和脊柱关节炎患者。
- 通过结构化访谈确定中位7年随访期间的心血管事件,采用Cox比例风险模型评估关联,受试者工作特征分析评估预测性能。
主要发现
- 143例患者中发生20例心血管事件;发生事件者基线cfPWV高于未发生者(10.06±2.16 m/s vs 8.8±2.3 m/s;p=0.024)。
- 两组SCORE2无差异(6.55±3.90% vs 5.61±4.39%,p=0.35)。
- cfPWV对心血管事件的AUC为0.84(95%CI 0.73至0.93),敏感度0.87,特异度0.73,优于SCORE2(AUC 0.56;95%CI 0.41至0.72;敏感度0.60,特异度0.69)。
- 年龄校正Cox回归中cfPWV仍是心血管事件的显著预测因子(HR 1.19,95%CI 1.00至1.39;p=0.047)。
- cfPWV与基线年龄(p<0.001)、平均动脉压(p=0.013)和C反应蛋白(p=0.011)相关。
关键数值与推荐
- cfPWV判别心血管事件AUC 0.84(95%CI 0.73至0.93),敏感度0.87,特异度0.73。
- SCORE2判别心血管事件AUC 0.56(95%CI 0.41至0.72),敏感度0.60,特异度0.69。
- 年龄校正后cfPWV预测心血管事件HR 1.19(95%CI 1.00至1.39;p=0.047)。
临床怎么用
- 对合并至少一项额外心血管危险因素的类风湿关节炎、系统性硬化症和脊柱关节炎患者,可考虑无创cfPWV评估以辅助长期心血管风险分层。
局限性
- 样本量较小(143例,20例事件),为回顾性单中心设计,需更大样本前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the prognostic value of carotid-femoral pulse wave velocity (cfPWV), a marker of aortic stiffness, for cardiovascular events (CVEs) in patients with autoimmune rheumatic diseases (ARDs) and to compare its performance with the Systematic Coronary Risk Evaluation 2 (SCORE2). METHODS: This retrospective cohort study included patients with rheumatoid arthritis, systemic sclerosis and spondyloarthritis who underwent clinically indicated baseline non-invasive cfPWV assessment between 2012 and 2017 because of at least one additional cardiovascular risk factor. CV risk was estimated using SCORE2 and SCORE2-OP in eligible patients. Incident CVEs were ascertained through structured interviews over a median 7-year follow-up. Associations were evaluated using Cox proportional hazards models and predictive performance using receiver operating characteristic analysis. RESULTS: Among 143 patients, 20 CVEs occurred. Baseline cfPWV was higher in patients who developed CVEs versus those who did not (10.06±2.16 m/s vs 8.8±2.3 m/s; p=0.024). SCORE2 did not differ between groups (6.55±3.90% vs 5.61±4.39%, p=0.35). cfPWV demonstrated strong discriminatory capacity for CVEs (area under the curve (AUC) 0.84; 95% CI (0.73 to 0.93), sensitivity 0.87, specificity 0.73), outperforming SCORE2 (AUC 0.56; 95% CI (0.41 to 0.72), sensitivity 0.60, specificity 0.69). In age-adjusted Cox regression, cfPWV remained a significant predictor of CVEs (HR 1.19, 95% CI (1.00 to 1.39); p=0.047). cfPWV correlated with baseline age (p<0.001), mean arterial pressure (p=0.013) and C reactive protein (p=0.011). DISCUSSION: cfPWV is an independent predictor of future CVEs in patients with ARDs and outperforms SCORE2 in long-term risk prediction. Given its non-invasive nature, cfPWV may provide incremental value for CV risk stratification in this high-risk population.
引用
- Triantafyllias K, Aldabbag M, Schepers M, et al. Carotid-femoral pulse wave velocity improves cardiovascular risk prediction beyond SCORE2 in autoimmune rheumatic diseases: a 7-year follow-up study. RMD Open. 2026. PMID: 42303381. doi:10.1136/rmdopen-2026-006847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。